AF Association Patients Day aims to bring together patients, carers and medical professionals to learn from each other and share experiences of living with Atrial Fibrillation.
Thank you to everyone who has contributed towards making this year's World Heart Rhythm Week a success
.jpg)
Heart Rhythm Congress
1-4 October, International Convention Centre (ICC), Birmingham, UK.
Cardiac Update Meetings
Our cardiac update meetings are for all healthcare professionals involved in the management and treatment of arrhythmias such as atrial fibrillation.
REACHES 1,000 SIGNATURES! Please pledge your support today and help us to double that number ready to submit to the National Screening Committee asking them to recommend a national AF screening programme for people 65 and over.
.jpg)
This website has been developed in partnership with Boehringer Ingelheim. It aims to raise awareness of Atrial Fibrillation (AF) and the importance of stroke prevention, featuring stories from across the AF community.
Submit your own example of best practice today to help improve care standards for AF patients around the world.
Working to provide information, support and access to established, new or innovative treatments for Atrial Fibrillation (AF)
Spotlight 2017: 40 Years of PCI The world's largest cardiovascular congress with over 500 experts sessions and 11 000 abstracts contributing to global awareness of the latest clinical trials and breakthrough discoveries. Abstract submission deadline: 14 Feb Clinical case submission deadline: 1 March Late Breaking Science deadline: 21 March Early Registration fee deadline: 31 May
Read more [external link]Cardiac tachyarrhythmias are recurrent or chronic and in some cases life-threatening conditions. Heart rhythm disturbances are often highly symptomatic and the psychological impact of the disease can be significant. Patients' beliefs and knowledge about their health (and illness), medications, and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses to their illness and treatment; adherence to recommended therapy; and ultimately affects health outcomes. Incorporation of patients' values and preferences for therapy should now be considered as an integral part of the decision-making process and treatment strategy. It is important to acknowledge and understand the impact of cardiac tachyarrhythmias on the patient. To address this issue, a Task Force was convened by the European Heart Rhythm Association (EHRA), and endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the published evidence available, to publish a joint consensus document on patient values and preferences for the management of cardiac tachyarrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice.
Read more [external link]
.png)
.svg.png)
